“…Thus, according to an established notion [21], the all-over outlook was worse for patients in early infancy [1,7,18,21, 23], whereas no substan tial differences between the 2 chemotherapy trials were observed in such a limited number of patients. The rate of survival till local recurrence has been related to the extent of the surgical removal [3,16,21,26,28] and to the type of radiation [3,14,15,20,21,[25][26][27]: our own findings -at least those concerning the group of longest survivors (table II) -seem to support such conclusion. No significant differences were otherwise observed concerning the effect of either antiblastic schedule on the ominous appearance of a local recurrence which, as usu ally, was the most frequent cause of death [2,15,17,21,25, 26],…”